Data gathered: April 15
AI Stock Analysis - Penumbra (PEN)
Analysis generated February 10, 2024. Powered by Chat GPT.
Penumbra is a global healthcare company that designs, develops, manufactures, and markets innovative medical devices. The company is specialized in products that address challenging medical conditions in markets such as neuro and peripheral vascular conditions. Penumbra's commitment to improving patient outcomes through cutting-edge technology has positioned it as a leader in its respective fields, fostering a reputation for innovation and quality.
Stock Alerts - Penumbra (PEN)
 |
Penumbra | April 9 Price is up by 5.8% in the last 24h. |
|
Penumbra | April 8 Business Outlook among employees is up by 4.2% over the last month. |
|
Penumbra | April 5 Insider Alert: Elsesser Adam is selling shares |
|
Penumbra | April 4 Price is down by -5.5% in the last 24h. |
Alternative Data for Penumbra
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 62 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 47,000 | Sign up | Sign up | Sign up |
| Employee Rating | 62 | Sign up | Sign up | Sign up |
| Google Trends | 100 | Sign up | Sign up | Sign up |
| Patents | 62 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 4 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,697 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 4 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 953 | Sign up | Sign up | Sign up |
| Twitter Followers | 4,128 | Sign up | Sign up | Sign up |
| Twitter Mentions | 61 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 3,900 | Sign up | Sign up | Sign up |
| News Mentions | 3 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 52 | Sign up | Sign up | Sign up |
| Linkedin Employees | 2,733 | Sign up | Sign up | Sign up |
About Penumbra
Penumbra, Inc., together with its subsidiairies, designs, develops, manufactures, and markets medical devices in the United States and internationally.
| Price | $270.27 |
| Target Price | Sign up |
| Volume | 386,340 |
| Market Cap | $10.5B |
| Year Range | $163.64 - $303.76 |
| Dividend Yield | 0% |
| PE Ratio | 778.06 |
| Analyst Rating | 75% buy |
| Earnings Date | April 23 '25 |
| Industry | Medical Devices |
In the news
 |
Penumbra price target lowered by $3 at BTIG, here's whyApril 14 - Thefly.com |
 |
Penumbra, Inc. (NYSE:PEN) Shares Acquired by O Shaughnessy Asset Management LLCApril 12 - ETF Daily News |
|
Reviewing Embecta (NASDAQ:EMBC) and Penumbra (NYSE:PEN)April 11 - ETF Daily News |
|
Penumbra price target lowered by $10 at Truist, here's whyApril 11 - Thefly.com |
|
Orion Portfolio Solutions LLC Sells 85 Shares of Penumbra, Inc. (NYSE:PEN)April 10 - ETF Daily News |
|
Prudential Financial Inc. Sells 478 Shares of Penumbra, Inc. (NYSE:PEN)April 10 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 301M | 101M | 200M | 30M | 36M | 0.850 |
| Q2 '24 | 299M | 77M | -77M | -60M | -70M | 0.640 |
| Q1 '24 | 279M | 98M | 181M | 11M | 18M | 0.410 |
| Q4 '23 | 285M | 98M | 187M | 54M | 41M | 0.760 |
| Q3 '23 | 271M | 93M | 178M | 9.2M | 15M | 0.670 |
Insider Transactions View All
| Elsesser Adam filed to sell 52,960 shares at $275.2. April 4 '25 |
| Elsesser Adam filed to sell 52,495 shares at $277.6. April 4 '25 |
| Wilder Thomas filed to sell 4,692 shares at $266.9. April 4 '25 |
| Elsesser Adam filed to sell 62,452 shares at $272. April 4 '25 |
| Elsesser Adam filed to sell 52,560 shares at $276. April 4 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$94.27 0% | 72 |
 |
Edwards LifesciencesEW |
$69.87 0% | 32 |
 |
Intuitive SurgicalISRG |
$490.13 0% | 66 |
 |
MedtronicMDT |
$84.22 0% | 47 |
 |
StrykerSYK |
$353.42 0% | 48 |
Read more about Penumbra (PEN) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Penumbra?
The Market Cap of Penumbra is $10.5B.
What is Penumbra's PE Ratio?
As of today, Penumbra's PE (Price to Earnings) ratio is 778.06.
When does Penumbra report earnings?
Penumbra will report its next earnings on April 23 '25.
What is the current stock price of Penumbra?
Currently, the price of one share of Penumbra stock is $270.27.
How can I analyze the PEN stock price chart for investment decisions?
The PEN stock price chart above provides a comprehensive visual representation of Penumbra's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Penumbra shares. Our platform offers an up-to-date PEN stock price chart, along with technical data analysis and alternative data insights.
Does PEN offer dividends to its shareholders?
As of our latest update, Penumbra (PEN) does not offer dividends to its shareholders. Investors interested in Penumbra should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Penumbra?
Some of the similar stocks of Penumbra are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.